Cite
HARVARD Citation
Janić, M. et al. (2022). Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes. Journal of diabetes research. p. . [Online].